Evelo Biosciences, Inc. (EVLO) Social Stream
EVELO BIOSCIENCES INC (EVLO) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering EVELO BIOSCIENCES INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 6 | $41.5 | $9 | $20.9 | $0.363 | 5657.58% |
| 2022-01-31 | 6 | $41.5 | $6 | $20.3 | $0.363 | 5492.29% |
| 2022-04-11 | 6 | $41.5 | $6 | $19.1 | $0.363 | 5161.71% |
| 2022-08-12 | 6 | $41.5 | $6 | $15.9 | $0.363 | 4280.17% |
| 2022-08-15 | 6 | $41.5 | $5 | $14.5 | $0.363 | 3894.49% |
| 2022-08-24 | 6 | $41.5 | $5 | $14.3 | $0.363 | 3839.39% |
| 2022-09-09 | 6 | $13 | $4 | $7.25 | $0.363 | 1897.25% |
| 2022-11-16 | 5 | $13 | $4 | $6.875 | $0.363 | 1793.94% |
| 2022-11-21 | 5 | $13 | $2.5 | $6.25 | $0.363 | 1621.76% |
| 2023-02-02 | 5 | $5 | $0.3 | $2.95 | $0.363 | 712.67% |
| 2023-02-15 | 5 | $5 | $0.3 | $2.45 | $0.363 | 574.93% |
| 2023-03-16 | 5 | $5 | $0.1 | $2.4 | $0.363 | 561.16% |
| 2023-05-17 | 5 | $2.5 | $0.1 | $1.4 | $0.363 | 285.67% |
| 2023-07-14 | 3 | $40 | $2 | $21 | $0.363 | 5685.12% |
| 2023-07-26 | 3 | $10 | $2 | $6 | $0.363 | 1552.89% |
| 2023-08-29 | 1 | $10 | $10 | $10 | $0.363 | 2654.82% |
| NA | 1 | $NA | $NA | $NA | $0.363 | NA% |
The Trend in the Analyst Price Target
EVLO's average price target has moved up $3.75 over the prior 41 weeks.
Over the past 30 weeks, EVLO's average upside potential has been 2,781.05%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-15 | 5 | 5.0 | 0.3 | 2.45 | 0.805 | 204.35% |
| 2023-04-10 | 5 | 2.5 | 0.1 | 1.40 | 0.217 | 545.16% |
| 2023-05-17 | 4 | 40.0 | 20.0 | 30.00 | 0.140 | 21328.57% |
| 2023-05-17 | 4 | 2.5 | 0.1 | 1.40 | 0.140 | 900% |
| 2023-07-14 | 3 | 40.0 | 2.0 | 21.00 | 3.610 | 481.72% |
EVLO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 0 | 0 | 1 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
EVLO's average broker recommendation rating worsened by 1.67 over the prior 52 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for EVLO as an investment opportunity.
- EVLO has a higher upside potential (average analyst target price relative to current price) than 2329.95% of all US stocks.
- In terms of how EVELO BIOSCIENCES INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -1986.37% of that group.
- EVELO BIOSCIENCES INC's average analyst price target is greater than 431.41% of Healthcare stocks.
- In terms of how EVELO BIOSCIENCES INC fares relative to Healthcare stocks, note that its number of analysts covering the stock is higher than 562.14% of that group.
In the Pharmaceutical Products industry, COGT, UBX, and FIXX are the three stocks most similar to EVELO BIOSCIENCES INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding EVLO using the data that counts. Try POWR Ratings for free.